---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-113653"
form_type: "8-K"
ticker: "HRGN"
cik: "0001563665"
company_name: "Harvard Apparatus Regenerative Technology, Inc."
filed_at: "2021-09-08T23:59:59+00:00"
generated_at: "2026-06-29T05:11:28.540233+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Biostage raises $2.6M in private placements, appoints Jerry He to board

## Summary
- Raised $2.0M in Sept 2021 from DST Capital and An Zhang in private placement of 1M shares and warrants for 500K shares at $2.00 per unit.
- Combined with $0.6M from earlier placements in May/June 2021, total cash infusion of $2.6M.
- Proceeds expected to fund operations and capex into Q4 2021.
- Appointed Jerry He (Executive Vice Chairman of Bright Scholar) as Class I independent director; options worth $25K + annual cash fees $20K.

## SEC filing metadata
- accession: 0001104659-21-113653
- form_type: 8-K
- ticker: HRGN
- cik: 0001563665
- company_name: Harvard Apparatus Regenerative Technology, Inc.
- filed_at: 2021-09-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563665/000110465921113653/0001104659-21-113653-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563665/000110465921113653/tm2127127d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-113653
- JSON: https://secwatch.observer/filing/0001104659-21-113653.json
- Plain text: https://secwatch.observer/filing/0001104659-21-113653.txt

## Key facts
- Executive change
  Junli He was appointed as Class I director at Harvard Apparatus Regenerative Technology, Inc..
  - Action: joined the Board
  - Role: Class I director
  source text: On September 1, 2021, Junli He, the Executive Vice Chairman of Bright Scholar Holdings, joined the Board of Directors (the “Board”) of the Company as a Class I director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563665/000110465921113653/0001104659-21-113653-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
